Ekso Bionics Holdings Inc (EKSO) — Cash Flow-to-Debt Ratio
Ekso Bionics Holdings Inc (EKSO) has a Cash Flow-to-Debt Ratio of -0.15x as of March 2026, meaning its operating cash flow of $-2.12 Million could theoretically repay 0% of its total liabilities ($13.93 Million) in one year. See Ekso Bionics Holdings Inc current assets vs equity to evaluate short-term liquidity relative to the company's equity base.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Ekso Bionics Holdings Inc Cash Flow-to-Debt Ratio (2012–2025)
Historical debt coverage capacity for Ekso Bionics Holdings Inc across 14 annual periods. Also explore net asset growth rate of Ekso Bionics Holdings Inc to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Ekso Bionics Holdings Inc (2012–2025)
Year-by-year debt coverage analysis for Ekso Bionics Holdings Inc. For market capitalisation and broader financial context, see EKSO market cap overview.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -1.06x | $-11.80 Million | $11.08 Million | ▼ -50.8% |
| 2024 | -0.71x | $-9.85 Million | $13.95 Million | ▲ +4.5% |
| 2023 | -0.74x | $-12.05 Million | $16.31 Million | ▲ +22.2% |
| 2022 | -0.95x | $-14.69 Million | $15.46 Million | ▼ -1.7% |
| 2021 | -0.93x | $-11.16 Million | $11.95 Million | ▼ -72.4% |
| 2020 | -0.54x | $-8.76 Million | $16.16 Million | ▲ +48.1% |
| 2019 | -1.04x | $-15.77 Million | $15.12 Million | ▲ +29.7% |
| 2018 | -1.48x | $-22.16 Million | $14.93 Million | ▲ +21.1% |
| 2017 | -1.88x | $-31.23 Million | $16.60 Million | ▼ -34.7% |
| 2016 | -1.40x | $-25.00 Million | $17.89 Million | ▼ -78.9% |
| 2015 | -0.78x | $-18.27 Million | $23.39 Million | ▲ +44.4% |
| 2014 | -1.41x | $-15.01 Million | $10.67 Million | ▼ -65.6% |
| 2013 | -0.85x | $-11.99K | $14.12K | ▲ +0.0% |
| 2012 | -0.85x | $-11.99K | $14.12K | — |